BIOMERICA INC - BMRA

Sector: Healthcare · Industry: In Vitro & In Vivo Diagnostic Substances
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$220K
QoQ value delta ($000)
-$25K (-10.2%)
Implied price effect (QoQ)
-10.86%
Shares
Total shares
89,452
QoQ shares delta
+657 (+0.74%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (BMRA)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 20 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
VANGUARD GROUP INC 53 21,127 0.0%
GEODE CAPITAL MANAGEMENT, LLC 46 18,627 0.0%
BlackRock, Inc. 46 18,636 0.0%
DRW Securities, LLC 42 16,925 0.0%
UBS Group AG 14 5,812 0.0%
NewEdge Advisors, LLC 9 3,603 0.0%
CITIGROUP INC 6 2,433 0.0%
HOLLENCREST CAPITAL MANAGEMENT 3 1,450 0.0%
CIBC Private Wealth Group LLC 1 662 0.0%
BANK OF AMERICA CORP /DE/ 0 49 0.0%
DANSKE BANK A/S 0 1 0.0%
HARBOUR INVESTMENTS, INC. 0 125 0.0%
SBI Securities Co., Ltd. 0 2 0.0%